期刊文献+

肿瘤显像剂S^11C-甲基-L-半胱氨酸的细胞摄取机制研究 被引量:1

Mechanism in cellular uptake of S-UC-methyl-L-cysteine as a tumor imaging agent
原文传递
导出
摘要 目的探讨肿瘤细胞摄取S^11C-甲基-L-半胱氨酸(^11C-MCYS)的机制。方法将Hepal-6肝癌细胞分为Na^+依赖组(NaCl组)及非Na^+依赖组(氯化胆碱组)进行氨基酸转运实验。每组又分为对照组、L-氨基酸转运载体抑制剂2-氨基二环.2,2,1-庚烷-2-羧酸(BCH)组、转运系统A和ASC的抑制剂α-甲基-氨基异丁酸(MeAIB)组、MeAIB+丝氨酸组,分别加入^11C-MCYS(400μl0.925MBq/ml)、^11C—MCYS(200μl1.85MBq/ml)+阻滞剂BCH(200μl 15mmol/L)、^11C-MCYS(200μl1.85MBq/ml)+阻滞剂MeAIB(200Ixl15mmol/L)以及“C.MCYS(200斗11.85MBq/ml)+阻滞剂MeAIB+丝氨酸(200斗l15mmol/L)。作用4min后终止培养应用1计数仪测量细胞放射性活度。将Hepal一6肝癌细胞分为5组,各组均加入200μl^11C—MCYS(1.85MBq/ml)后分别加入50、100、200、300、350μmol/L浓度不等的MCYS进行竞争抑制实验。培养4min后终止培养应用γ计数仪测量细胞放射性活度。结果无论是否有Na^+存在,对照组、BCH组、MeAIB及MeAIB+丝氨酸组对^11C—MCYS摄取的差异均无统计学意义(均P〉0.05)。MeAIB组和MeAIB+丝氨酸组中的NaCl组细胞放射性活性与氯化胆碱组相比差异均无统计学意义(18958.18±97.32比20582.27±196.32,18385.24±122.96比21620比±131.41,均P〉0.05),两者均不能抑制Na^+非依赖性氨基酸转运载体的转运。而BCH组中的NaCl组细胞放射性活性高于氯化胆碱组(2587.21±+30.25比2340.61±21.09,P〈0.05),可见BCH能明显抑制Na^+非依赖性氨基酸转运体对^11C-MCYS的转运。不同浓度MCYS(50~350μmol/L)作用下肿瘤细胞对^11C-MCYS摄取差异无统计学意义(均P〉0.05)。结论肿瘤细胞摄取^11C-MCYS是通过非Na^+依赖的L-氨基酸转运系统进行转运的,极少涉及氨基酸转运系统A和ASC。 Objective To investigate the mechanism in uptake of S-11C-methyl-L-cysteine(11C- MCYS) by tumor cells. Methods Hepal-6 cells were divided into Na^+ dependent (NaC1 group) and non- Na^+ dependent (choline chloride group) groups for amino acids transport experiment. The two groups were then divided into control group, 2′-aminobicyclo(2, 2, 1) - heptane-2′-carboxylic acid (BCH, L-amino acid transporter inhibitor) , N-methylamino-isobutyric acid (MeAIB, transport system inhibitor of A and ASC) and MeAIB+serine groups. All the groups were added with ^11C-MCYS (400 μl 0.925 MBq/ml), HC- MCYS(200 μl 1.85 MBq/ml)+ BCH(200 μl 15 mmol/L), ^11C-MCYS(200 μl 1.85 MBq/ml)+ MeAIB(200 μl 15 mmol/L), ^11C-MCYS(200 μl 1.85 MBq/ml)+ MeAIB+serine(200 μl 15 mmol/L) respectively. After 4 min, the incubation was discontinued, and the cell radioactivity was measured with γ counter. Thereafter,Hepa 1-6 cells were classified into five groups which were added with 200 μl ^11C-MCYS (1.85 MBq/ml)and then different concentrations of MCYS (50, 100, 200, 300, 350 μmol/L) for a competitive inhibition experiment. γcounter was used to measure the radioactivity at 4 mins after incubation. Results There were no significant differences in uptake of ^11C- MCYS by control, BCH, MeAIB and MeAIB+serine groups with or without the presence of Na ^+ (P〉0.05). In MeAIB and MeAIB + serine groups, the NaCl and choline chloride sub- groups showed no significant differences in radioactivity (18 958.18±97.32 vs 20 582.27± 196.32, 18 385.24 ± 122.96 vs 21 620.54 ± 131.41, both P〉0.05) and could not inhibit the transportation of non-Na^+ dependent amino acid carrier. However in BCH group, the radioactivity in NaCl group was higher than that in choline chloride group (2587.21± 30.25 vs 2340.61 ±21.09, P〈0.05). Thus, BCH could significantly inhibit the transportation of ^11C-MCYS by non-Na^+ dependent amino acid carrier. No significant differences were found in uptake of ^11C-MCYS by tumor cells under different concentrations of MCYS(50 - 350 μmol/L) (all P〉0.05). Conclusion The uptake of nC-MCYS is the result of transportation through non- Na^+ dependent L-amino acid transport system, with minimal involvement of amino acid transport system A and ASC.
出处 《中华生物医学工程杂志》 CAS 2012年第1期41-44,共4页 Chinese Journal of Biomedical Engineering
关键词 S-^11C-甲基-L-半胱氨酸 氨基酸转运系统 中性 正电子发射断层显像术 肝肿 实验性 细胞摄取 S - 11C - methyl - L - cysteine Amino acid transport systems, neutral Positron -emission tomography Liver neoplasms, experimental Cell uptake
  • 相关文献

参考文献10

  • 1Deng H, Tang X, Tang G, et al. S-llC-methyl-L-cysteine: a new amino acid PET tracer for cancer imagimg. J Nucl Med, 2001, 52 : 287-293.
  • 2Langen KJ, Jaroseh M, Muhlensiepen H, et al. Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas. Nucl Med Biol, 2003, 30: 501-508.
  • 3Langen KJ, Muhlensiepen H, Schmieder S, et al. Transport of cis- and trans-4-[ lSF]fluoro-L-proline in F98 gliomas ceils. Nucl Med Biol, 2002, 29: 685-692.
  • 4唐刚华.肿瘤氨基酸代谢正电子发射断层显像[J].第一军医大学学报,2002,22(12):74-77.
  • 5Laverman P, Boerman OC, Corstens FH, et al. Fluorinated amino acids for tumour imaging with positron emission tomography. Eur J Nucl Med Mol Imaging, 2002, 29: 681-690.
  • 6Asano S, Kameyama M, Oura A, et al. L- type amino acid transporter-1 expressed in human astrocytomas, U343MGa. Biol Pharm Bull, 2007, 30: 415-422.
  • 7Haase C, Bergmann R, Fuechtner F, et al. L-type amino acid transporters LAT1 and LAT4 in cancer: uptake of 3-O-methyl-6- lSF- fluoro-L-Dopa in human adenocarcinoma and squamous ceil carcinoma in vitro and in vivo. J Nucl Med, 2007, 48: 2063- 2071.
  • 8Okubo S, Zhen H, Kawai N, et al. Correlation of L-methyl-llC- methionine (MET) uptake with L-type amino acid transporter 1 in human gliomas. J Neurooncol, 2010, 99: 217-225.
  • 9McConathy J, Goodman MM. Non-natural amino acids for tumor imaging using positron emission tomography and single photon emission computed tomography. Cancer Metastasis Rev, 2008, 27 : 555-573.
  • 10Sklan NM, Barnsley EA. The metabolism of S-methyl-L-cysteine. Biochem J, 1968, 107: 217-223.

共引文献4

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部